Press Release: Roll for a Reason Gala Raises $150,000

December 19, 2016 – Pittsburgh, PA

Clear Thoughts Foundation (CTF) held its second annual Roll for a Reason Gala on Saturday, November 12th at J. Verno Studio in the historic South Side area of Pittsburgh. CTF held this gala to raise funds so they can further their mission to accelerate the discovery of drugs/therapeutics that will stop dementia.

A crowd of 350+ attendees helped CTF meet its goal of raising $150,000 for dementia research. The Monte Carlo Casino Night was emceed by Star 100.7’s Bubba. Lots of fun was had by all who chanced their luck at poker, blackjack, roulette, craps and slots. We thank our celebrity dealers in attendance for helping our guests to enjoy the evening. There were several surprises including one-of-akind live auction items, and art amazingly created on the spot by artist George Williams, and magic by Lee Terbosic.

The evening was full of activity starting with a welcome from Board member Matthew Jameson and update from CTF Founder and President, Hayley Jameson. Hayley publically awarded a $50,000 grant to Amantha Thathiah of The Pittsburgh Institute for Neurodegenerative Diseases (PIND). Specifically, the grant will go to Dr. Thathiah’s application entitled “Role of GPCRs in Alzheimer’s Disease.” This research will provide valuable knowledge in the area of Alzheimer’s research, which in turn can further the treatment of all dementias.

The attendees also heard two heartfelt stories from two ladies who are currently being affected by dementia through family members who are struggling with the disease.

Clear Thoughts Foundation (CTF) is a 501©3 not-for-profit organization. CTF was established in Pittsburgh in 2010, with the primary purpose to raise funds to discover drugs and novel therapeutics (biogenetics), stem cells etc.) to stop the effects of dementia and eventually end this terrible disease. All of the founding members of CTF have had some personal experience with dementia, such as Alzheimer’s or other related cognitive disorders, and have been disappointed with the lack of available and effective drugs and therapeutics in today’s market.

More information is available at